Back to Search
Start Over
Worsening of COVID-19 after chemotherapy in patients considered to have recovered from a SARS-CoV-2 infection.
- Source :
-
Leukemia & Lymphoma . Jan2022, Vol. 63 Issue 1, p253-255. 3p. - Publication Year :
- 2022
-
Abstract
- In another study, no reactivation was documented following chemotherapy in patients previously infected with SARS-CoV-2, but all patients had negative SARS-CoV-2 PCR on NPS and positive SARS-CoV-2 serology before receiving chemotherapy [[11]]. Given the increased risk of infection after chemotherapy, hematological societies have proposed postponing chemotherapy, when feasible, during the COVID-19 pandemic [[1]], despite initial studies showing no increase in the incidence of COVID-19 among hematological patients [[2]]. It is noteworthy that all three patients had negative serology for SARS-CoV-2 more than one month after their first positive PCR for SARS-CoV-2, suggesting that these patients were not able to develop a humoral immune response against SARS-CoV-2. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 10428194
- Volume :
- 63
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Leukemia & Lymphoma
- Publication Type :
- Academic Journal
- Accession number :
- 154569798
- Full Text :
- https://doi.org/10.1080/10428194.2021.1978086